Posts by: Alejandra Viviescas, PhD.

Alejandra Viviescas, PhD.

April 16, 2019

Heart Valve Damage Might Be Cause of Breathing Difficulties in ANCA-Associated Vasculitis, Case Report Says

News

While breathing difficulties in ANCA-associated vasculitis patients are often a symptom of worsening vasculitis in their lungs, doctors should also consider cardiac valve involvement — or damage to heart valves — ... Read more

April 15, 2019April 15, 2019

Donor Antibodies Given Intravenously May Treat ANCA Vasculitis, Early Study Reports

News

Intravenous immunoglobulin therapy – which essentially consists on pooled antibodies from a thousand or more blood donors – could be a promising way of treating MPO-positive ANCA-associated vasculitis patients, ... Read more

April 2, 2019

PR3-ANCA Vasculitis May Cause Internal Organ Damage Due to Inadequate Blood Supply, Case Report Suggests

News

Patients with ANCA-associated vasculitis producing PR3-ANCA antibodies may have inadequate blood delivery to internal organs, such as the kidneys and spleen, leading to organ malfunction and pain, a case ... Read more

March 5, 2019

Low-dose Radiotherapy Could Treat Cancer Caused by GPA Lesions, Case Report Suggests

News

Tumors caused by granulomatosis with polyangiitis (GPA)-related lesions appear to be especially sensitive to radiation and can be treated effectively with low-dose radiotherapy, a case report suggests. The study, “Radiotherapy ... Read more

February 26, 2019

Study: IV Methylprednisolone Doesn’t Benefit, May Harm AAV Patients

News

Adding intravenous methylprednisolone pulses to standard treatment for inducing remission in severe cases of ANCA-associated vasculitis does not confer clinical benefits and increases the risk of infection and diabetes, a study suggests. ... Read more

February 21, 2019

New Test May Help Determine Disease Activity in GPA Patients, Study Reports

News

A new test measuring the relative abundance of immunoglobulin G4 (IgG4) RNA could be an indicator of granulomatosis with polyangiitis (GPA) activity and distinguish active disease from remission, a study suggests. ... Read more

February 14, 2019

Reduced Muscle Strength Leads to Poor Quality of Life in ANCA Vasculitis Patients, Study Says

News

Long-term disease and treatment-related damage reduce the muscle strength and physical capacity of people with ANCA-associated vasculitis. The resulting reduction in physical activity diminishes the quality of life, a ... Read more

February 7, 2019February 7, 2019

Radiotherapy Should Be Done Carefully on GPA Patients with Cancer to Avoid Complications, Case Study Suggests

News

The use of radiation therapy on granulomatosis with polyangiitis (GPA) patients with cancer should be done with caution to avoid potential complications, a case report suggests. The study, “Lower cranial nerve palsy ... Read more

January 28, 2019

Gene Expression Analysis of AAV Tissue Sheds New Light on Disease Progression, Study Finds

News

An analysis of the gene expression and gene pathways in different tissues affected by ANCA vasculitis has provided new information about the mechanisms involved in disease progression, a study ... Read more

January 14, 2019

Omalizumab May Reduce Asthma Symptoms and Steroid Requirement in EGPA Patients, Study Shows

News

Omalizumab, an injectable medication approved for allergic asthma, might reduce asthma symptoms and steroid dosages in patients with eosinophilic granulomatosis with polyangiitis (EGPA), according to a retrospective study. The study, “Omalizumab in ... Read more

Pin It on Pinterest